MYL9 and colorectal carcinoma: More convincingly, GEPIA also indicated a decreased overall and disease-free survival rates in CRC patients with highly expressed (n=135) MYL9 and CNN1 (MYL9 overall: P=0.0071, disease-free: P=0.021; CNN1 overall: P=0.0089, disease-free: P=0.018, Fig. 6e-l).